Intended for healthcare professionals

CCBYNC Open access
Research

Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis

BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g5459 (Published 01 October 2014) Cite this as: BMJ 2014;349:g5459